Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections. Postgraduate medicine [Postgrad Med] Journal article

Title	Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections.
Author(s)	Kikano G
Institution	Department of Family Medicine, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA. gek@case.edu
Source	Postgrad Med 2009 May; 121(3):173-5.
MeSH	Acute Disease Administration, Oral Adolescent Adult Aged Delayed-Action Preparations Diagnosis, Differential Dose-Response Relationship, Drug Drug Combinations Expectorants Female Follow-Up Studies Guaifenesin Humans Male Middle Aged Nasal Decongestants Pseudoephedrine Respiratory Tract Infections Time Factors Treatment Outcome Young Adult
Abstract	Acute bacterial respiratory infections (ABRIs) require treatment with antibiotics. Although antibiotics may address the underlying pathogenic factors, over-the-counter (OTC) agents can play an adjuvant role in relieving mucus-related symptoms. This complimentary role contributes to the healing process and is supported by current clinical guidelines.
Language	eng
Pub Type(s)	Comment Comparative Study Journal Article Randomized Controlled Trial
PubMed ID	19491556

Advertise on this site.